HMGB1 and keratitis: Our focus on microbial keratitis supports the tenet that inhibition of HMGB1 is successful at reducing keratitis in rodent models and that one of the inhibitors, GLY also potentiates antibiotic treatment against both non, as well as multi-drug resistant isolates, even when treatment is begun almost a day after infection.